Abbvie INC ABBVIE ORD SHS
Abbvie INC ABBVIE ORD SHS/ US00287Y1091 /
0QCV
|
2024-04-16 6:34:01 PM
|
Chg.
+0.69
|
Volume |
Bid2024-04-16 |
Ask2024-04-16 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
163.36USD
|
+0.42%
|
325,062
Turnover: - |
-Bid Size: - |
-Ask Size: - |
287.12 bill.USD |
3.69% |
59.54 |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
2.73 USD |
-58.95% |
| EPS Diluted: |
2.72 USD |
-58.97% |
| Revenues per Share: |
30.75 USD |
-6.28% |
| Book Value per Share: |
5.89 USD |
-39.76% |
| Cash Flow per Share: |
12.93 USD |
-8.28% |
| Dividend per Share: |
5.99 USD |
4.90% |
| Total |
in mill. |
|
| Revenues: |
54,318.00 USD |
-6.44% |
| Net Income: |
4,863.00 USD |
-58.91% |
| Operating Cash Flow: |
22,839.00 USD |
- |
| Cash and Cash Equivalents: |
12,814.00 USD |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
59.54 |
56.77 |
| P/S Ratio: |
5.29 |
5.04 |
| P/BV ratio: |
27.62 |
26.33 |
| P/CF Ratio: |
12.57 |
11.99 |
| PEG: |
-1.01 |
-0.96 |
| Earnings Yield: |
1.68% |
1.76% |
| Dividend Yield: |
3.69% |
3.87% |
| Market Capitalization |
|
| Market Capitalization: |
287.12 bill. USD |
273.75 bill. USD |
| Free Float Market Cap.: |
- USD |
- USD |
| Market Cap. / Employee: |
- USD |
- USD |
| Shares Outstanding: |
1.77 bill. |
|
Profitability
| Gross Profit Margin: |
62.42% |
| EBIT Margin: |
23.49% |
| Net Profit Margin: |
8.95% |
| Return on Equity: |
46.77% |
| Return on Assets: |
3.61% |
Financial Strength
| Liquidity I / Cash Ratio: |
33.86% |
| Liquidity II / Quick Ratio: |
63.34% |
| Liquidity III / Current Ratio: |
87.21% |
| Debt / Equity Ratio: |
1,195.67% |
| Dynam. Debt / Equity Ratio: |
544.31% |
Efficiency
| Employees: |
- |
| Personal Expenses / Employee: |
- USD |
| Revenues / Employee: |
- USD |
| Net Income / Employee: |
- USD |
| Total Assets / Employee: |
- USD |
| * Fiscal Year End: |
2023-12-31 |
| Accounting Standard: |
US GAAP |
